Catalyst Wire Dossier Catalyst Wire Dossier

Influenza vaccine (non-adjuvanted split virion)

influenza vaccine split virion non-adjuvanted · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Influenza vaccine (non-adjuvanted split virion), covering 2016-12-01 to 2016-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study [Phase 2]

See pricing